Reciprocal translocations in breast tumor cell lines: Cloning of a t(3;20) that targets the FHIT gene

Genes Chromosomes and Cancer

Volumn 35, Issue 3, 2002, Pages 204-218

  Popovici, Cornel ^a   Basset, Céline ^a   Bertucci, François ^a   Orsetti, Béatrice ^b   Adélaide, José ^a   Mozziconacci, Marie Joëlle ^a   Conte, Nathalie ^a,c   Murati, Anne ^a   Ginestier, Christophe ^a   Charafe Jauffret, Emmanuelle ^a   Ethier, Stephen P ^d   Lafage Pochitaloff, Marina ^a   Theillet, Charles ^b   Birnbaum, Daniel ^a,c   Chaffanet, Max ^a  

^a INSTITUT PAOLI CALMETTES   (France)

^b CENTRE VAL D AURELLE   (France)

^c INSERM   (France)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CELL; BREAST TUMOR; CHROMOSOME TRANSLOCATION 20; CHROMOSOME TRANSLOCATION 3; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; EVALUATION; FEMALE; FHIT GENE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE FREQUENCY; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYBRIDIZATION; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE; YEAST ARTIFICIAL CHROMOSOME;

ACID ANHYDRIDE HYDROLASES; BASE SEQUENCE; BREAST NEOPLASMS; CHROMOSOME BANDING; CHROMOSOME BREAKAGE; CHROMOSOME DELETION; CHROMOSOME FRAGILITY; CHROMOSOME MAPPING; CHROMOSOME PAINTING; CHROMOSOMES, ARTIFICIAL, YEAST; CHROMOSOMES, HUMAN, PAIR 20; CHROMOSOMES, HUMAN, PAIR 3; CLONING, MOLECULAR; EXONS; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 18544382390     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10107     Document Type: Article

References (55)

1. Adálaïde J, Chaffanet M, Imbert A, Allione F, Geneix J, Popovici C, van Alewijk D, Trapman J, Zeillinger R, Borresen-Dale AL, Lidereau R, Birnbaum D, Pébusque MJ. 1998. Chromosome region 8p11-p21: refined mapping and molecular alterations in breast cancer. Genes Chromosomes Cancer 22:186-199.
2. Adélaïde J, Chaffanet M, Mozziconacci MJ, Popovici C, Conte N, Fernandez F, Sobol H, Jacquemier J, Pébusque MJ, Ron D, Lafage-Pochitaloff M, Birnbaum D. 2000. Translocation and coamplification of loci from chromosome arms 8p and 11q in the MDA-MB-175 mammary carcinoma cell line. Int J Oncol 16:683-688.
3. Adeyinka A, Mertens F, Idvall I, Bondeson L, Ingvar C, Heim S, Mitelman F, Pandis N. 1998. Cytogenetic findings in invasive breast carcinomas with prognostically favourable histology: a less complex karyotypic pattern. Int J Cancer 79:361-364.
4. Ahmadian M, Wistuba II, Fong KM, Behrens C, Kodagoda DR, Saboorian MH, Shay J, Tomlinson GE, Blum J, Minna JD, Gazdar AF. 1997. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands. Cancer Res 57:3664-3668.
5. Campiglio M, Pekarsky Y, Menard S, Tagliabue E, Pilotti S, Croce CM. 1999. FHIT loss of function in human primary breast cancer correlates with advanced stage of the disease. Cancer Res 59:3866-3869.
6. Chaffanet M, Imbert A, Adélaïde J, Le Paslier D, Wagner MJ, Wells DE, Birnbaum D, Pébusque M-J. 1996. A 3.1-Mb YAC contig within the Werner syndrome region, on the short arm of human chromosome 8. Cytogenet Cell Genet 72:63-68.
7. Chudoba I, Plesch A, Lorch T, Lemke J, Claussen U, Senger G. 1999. High resolution multicolor-banding: a new technique for refined FISH analysis of human chromosomes. Cytogenet Cell Genet 84:156-160.
8. Courjal F, Theillet C. 1997. Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification. Cancer Res 57:4368-4377.
9. Courtay-Cahen C, Morris JS, Edwards PA. 2000. Chromosome translocations in breast cancer with breakpoints at 8p12. Genomics 66:15-25.
10. Croce CM, Sozzi G, Huebner K. 1999. Role of FHIT in human cancer. J Clin Oncol 17:1618-1624.
11. Davidson JM, Gorringe KL, Chin SF, Orsetti B, Besret C, Courtay-Cahen C, Roberts I, Theillet C, Caldas C, Edwards PA. 2000. Molecular cytogenetic analysis of breast cancer cell lines. Br J Cancer 83:1309-1317.
12. Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissette J, Weissenbach J. 1996. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 380:152-154.
13. Druck T, Hadaczek P, Fu TB, Ohta M, Siprashvili Z, Baffa R, Negrini M, Kastury K, Veronese ML, Rosen D, Rothstein J, McCue P, Cotticelli MG, Inoue H, Croce CM, Huebner K. 1997. Structure and expression of tire human FHIT gene in normal and tumor cells. Cancer Res 57:504-512.
14. Dutrillaux B, Gerbault-Seureau M, Zafrani B. 1990. A comparison of 30 paradiploid cases with few chromosome changes. Cancer Genet Cytogenet 49:203-217.
15. Fang JM, Arlt MF, Burgess AC, Dagenais SL, Beer DG, Glover TW. 2001. Translocation breakpoints in FHIT and FRA3B in both homologs of chromosome 3 in an esophageal adenocarcinoma. Genes Chromosomes Cancer 30:292-298.
16. Flagiello D, Gerbault-Seureau M, Sastre-Garau X, Padoy E, Vielh P, Dutrillaux B. 1998. Highly recurrent der(1;16)(q10;p10) and other 16q arm alterations in lobular breast cancer. Genes Chromosomes Cancer 23:300-306.
17. Fong LY, Fidanza V, Zanesi N, Lock LF, Siracusa LD, Mancini R, Siprashvili Z, Ottey M, Martin SE, Druck T, McCue PA, Croce CM, Huebner K. 2000. Muir-Torre-like syndrome in Fhit-deficient mice. Proc Natl Acad Sci USA 97:4742-4747.
18. Forozan F, Veldman R, Ammerman CA, Parsa NZ, Kallioniemi A, Kallioniemi OP, Ethier SP. 1999. Molecular cytogenetic analysis of 11 new breast cancer cell lines. Br J Cancer 81:1328-1334.
19. Gemmill RM, West JD, Boldog F, Tanaka N, Robinson LJ, Smith DI, Li F, Drabkin HA. 1998. The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a patched-related gene, TRC8. Proc Natl Acad Sci USA 95:9572-9577.
20. Gerbault-Seureau M, Vielh P, Zafrani B, Salmon R, Dutrillaux B. 1987. Cytogenetic study of twelve human near-diploid breast cancers with chromosomal changes. Ann Genet 30:138-145.
21. Geurts JM, Schoenmakers EF, Roijer E, Stenman G, Van de Ven WJ. 1997. Expression of reciprocal hybrid transcripts of HMGIC and FHIT in a pleomorphic adenoma of the parotid gland. Cancer Res 57:13-17.
22. Hainsworth PJ, Raphael KL, Stillwell RG, Bennett RC, Garson OM. 1991. Cytogenetic features of twenty-six primary breast cancers. Cancer Genet Cytogenet 53:205-218.
23. Hayashi S, Tanimoto K, Hajiro-Nakanishi K, Tsuchiya E, Kurosumi M, Higashi Y, Imai K, Suga K, Nakachi K. 1997. Abnormal FHIT transcripts in human breast carcinomas: a clinicopathological and epidemiological analysis of 61 Japanese cases. Cancer Res 57:1981-1985.
24. Huebner K, Garrison PN, Barnes LD, Croce CM. 1998. The role of the FHIT/FRA3B locus in cancer. Ann Rev Genet 32:7-31.
25. Ingvarsson S. 2001. FHIT alterations in breast cancer. Semin Cancer Biol 11:361-366.
26. Ingvarsson S, Agnarsson BA, Sigbjornsdottir BI, Kononen J, Kallioniemi OP, Barkardottir RB, Kovatich AJ, Schwarting R, Hauck WW, Huebner K, McCue PA. 1999. Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas. Cancer Res 59:2682-2689.
27. Inoue H, Ishii H, Alder H, Snyder E, Druck T, Huebner K, Croce CM. 1997. Sequence of the FRA3B common fragile region: implications for the mechanism of FHIT deletion. Proc Natl Acad Sci USA 94:14584-14589.
28. Kallioniemi OP, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW, Pinkel D. 1994. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10:231-243.
29. Kytölä S, Rummukainen J, Nordgren A, Karhu R, Farnebo F, Isola J, Larsson C. 2000. Chromosomal alterations in 15 breast cancer cell lines by comparative genomic hybridization and spectral karyotyping. Genes Chromosomes Cancer 28:308-317.
30. Lafage M, Pedeutour F, Marchetto S, Simonetti J, Prosperi M-T, Gaudray P, Birnbaum D. 1992. Fusion and amplification of two originally non-syntenic chromosomal regions in a mammary carcinoma cell line. Genes Chromosomes Cancer 5:40-49.
31. Liu X, Baker E, Eyre HJ, Sutherland GR, Zhou M. 1999. Gamma-heregulin: a fusion gene of DOC-4 and neuregulin-1 derived from a chromosome translocation. Oncogene 18:7110-7114.
32. Mitelman F, Mertens F, Johansson B. 1997. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 15:417-474.
33. Mitelman F, Johansson B, Mertens F, editors. 2001. Mitelman database of chromosome aberrations in cancer. http://cgap.nci. nih.gov/Chromosomes/Mitelman
34. Möbus VJ, Moll R, Gerharz CD, Kieback DG, Merk O, Runnebaum IB, Linner S, Dreher L, Grill HJ, Kreienberg R. 1998. Differential characteristics of two new tumorigenic cell lines of human breast carcinoma origin. Int J Cancer 77:415-423.
35. Negrini M, Monaco C, Vorechovsky I, Ohta M, Druck T, Baffa R, Huebner K, Croce CM. 1996. The FHIT gene at 3p14.2 is abnormal in breast carcinomas. Cancer Res 56:3173-3179.
36. Pandis N, Heim S, Bardi G, Idvall I, Mandahl N, Mitelman F. 1993. Chromosome analysis of 20 breast carcinomas: cytogenetic multiclonality and karyotypic-pathologic correlations. Genes Chromosomes Cancer 6:51-57.
37. Pandis N, Jin Y, Gorunova L, Petersson C, Bardi G, Idvall I, Johansson B, Ingvar C, Mandahl N, Mitelman F, Heim S. 1995. Chromosome analysis of 97 primary breast carcinomas: identification of eight karyotypic subgroups. Genes Chromosomes Cancer 12:173-185.
38. Persson K, Pandis N, Mertens F, Borg A, Baldetorp B, Killander D, Isola J. 1999. Chromosomal aberrations in breast cancer: a comparison between cytogenetics and comparative genomic hybridization. Genes Chromosomes Cancer 25:115-122.
39. Richards RI. 2001. Fragile and unstable chromosomes in cancer: causes and consequences. Trends Genet 17:339-345.
40. Ried K, Finnis M, Hobson L, Mangelsdorf M, Dayan S, Nancarrow JK, Woollatt E, Kremmidiotis G, Gardner A, Venter D, Baker E, Richards RI. 2000. Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. Hum Mol Genet 9:1651-1663.
41. Schröck E, du Manoir S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith MA, Ning Y, Ledbetter DH, Bar-Am I, Soenksen D, Garini Y, Ried T. 1996. Multicolor spectral karyotyping of human chromosomes. Science 273:494-497.
42. Speicher MR, Ballard SG, Ward DC. 1996. Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nat Genet 12:368-375.
43. Steinarsdottir M, Petursdottir I, Snorradottir S, Eyfjord JE, Ogmundsdottir HM. 1995. Cytogenetic studies of breast carcinomas: different karyotypic profiles detected by direct harvesting and short-term culture. Genes Chromosomes Cancer 13:239-248.
44. Teixeira MR, Pandis N, Bardi G, Andersen JA, Bohler PJ, Qvist H, Heim S. 1997. Discrimination between multicentric and multifocal breast carcinoma by cyrogenetic investigation of macroscopically distinct ipsilateral lesions. Genes Chromosomes Cancer 18:170-174.
45. Telenius H, Carter NP, Bebb CE, Nordenskjold M, Ponder BA, Tunnacliffe A. 1992. Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics 13:718-725.
46. Theillet C, Adélaïde J, Louason G, Bonnet-Dorion F, Jacquemier J, Adnane J, Longy M, Katsaros D, Sismondi P, Gaudray P, Birnbaum D. 1993. FGFR1 and PLAT genes and DNA amplification at 8p12 in breast and ovarian cancers. Genes Chromosomes Cancer 7:219-226.
47. Thompson F, Emerson J, Dalton W, Yang JM, McGee D, Villar H, Knox S, Massey K, Weinstein R, Bhattacharyya A, Trent J. 1993. Clonal chromosome abnormalities in human breast carcinomas. I. Twenty-eight cases with primary disease. Genes Chromosomes Cancer 7:185-193.
48. Tomlinson GE, Chen TT, Stastny VA, Virmani AK, Spillman MA, Tonk V, Blum JL, Schneider NR, Wistuba II, Shay JW, Minna JD, Gazdar AF. 1998. Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier. Cancer Res 58:3237-3242.
49. Trent J, Yang JM, Emerson J, Dalton W, McGee D, Massey K, Thompson F, Villar H. 1993. Clonal chromosome abnormalities in human breast carcinomas. II. Thirty-four cases with metastatic disease. Genes Chromosomes Cancer 7:194-203.
50. Wang L, Darling J, Zhang JS, Liu W, Qian J, Bostwick D, Hartmann L, Jenkins R, Bardenhauer W, Schutte J, Opalka B, Smith DI. 2000. Loss of expression of the DRR1 gene at chromosomal segment 3p21.1 in renal cell carcinoma. Genes Chromosomes Cancer 27:1-10.
51. Wang XZ, Jolicoeur E, Conte N, Chaffanet M, Zhang Y, Mozziconacci MJ, Feiner H, Birnbaum D, Pébusque MJ, Ron D. 1999. γ-Heregulin is the product of a chromosomal translocation fusing the DOC4 and HGL/NRG1 genes in the MDA-MB-175 breast cancer cell line. Oncogene 18:5718-5721.
52. Wistuba II, Behrens C, Milchgrub S, Syed S, Ahmadian M, Virmani AK, Kurvari V, Cunningham TH, Ashfaq R, Minna JD, Gazdar AF. 1998. Comparison of features of human breast cancer cell lines and their corresponding tumors. Clin Cancer Res 4:2931-2938.
53. Yuan BZ, Keck-Waggoner C, Zimonjic DB, Thorgeirsson SS, Popescu NC. 2000. Alterations of the FHIT gene in human hepatocellular carcinoma. Cancer Res 60:1049-1053.
54. Zanesi N, Fidanza V, Fong LY, Mancini R, Druck T, Valtieri M, Rudiger T, McCue PA, Croce CM, Huebner K. 2001. The tumor spectrum in FHIT-deficient mice. Proc Natl Acad Sci USA 98:10250-10255.
55. Zöchbauer-Müller S, Fong KM, Maitra A, Lam S, Geradts J, Ashfaq R, Virmani AK, Milchgrub S, Gazdar AF, Minna JD. 2001. 5′ CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer. Cancer Res 61:3581-3585.